A record of what Chakri Lokapriya said publicly, with the source. Not advice.
Pending — not yet graded
“Bullish on export-facing pharmaceutical companies like Glenmark and Dr Reddy's, expecting slightly higher earnings growth due to global recovery and new product launches. These companies offer valuation comfort and are anticipated to grow much faster than the Nifty.”
Nifty PharmaBullishCalled 07 Jan 2025
This call has no verdict yet — it is graded HIT or MISS against real price data once a close decides it. Save it above to find it again from your profile.
Read the original articleSee Chakri Lokapriya’s full track record